EDAP TMS SA ADR
EDAP TMS SA ADR (FOCL) Wheel Strategy
FOCL wheel strategy scan found 1 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 14.0%.
Read more
Running a FOCL wheel strategy lets you generate consistent premium income on EDAP TMS SA ADR while setting your own entry and exit prices on the underlying. EDAP TMS SA ADR's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own FOCL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best FOCL wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on FOCL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable FOCL wheel from a losing one.
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications.
This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the FOCL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your FOCL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Mar 19, 2027 | 2.50 | $0.05 | $0.18 | -0.11 | 182 | — | 53.2% | 14.0% | 1 |
As of September 22, 2026
Run the Wheel on FOCL With Confidence
Find the best FOCL wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→